NEWS COMMENTARY

Metamaterial Technologies (MTI) acquires MediWiSe; no products released to date

Published:
July 29, 2019
Services:
Consumer More...
Activities:
Acquisition
Average importance

During our conversation in 2017, MTI said it was in the process of developing an MRI-related device and acquiring an undisclosed health company. Since acquiring MediWiSe in 2018, MTI changed tracks, and it is now working on a noninvasive glucose monitor, yet to be released. While metamaterials as a technology can be made sensitive to specific frequencies, there is a long development road ahead. Moreover, the medical market is difficult to penetrate, and this move will not reap short-term reward for a company arguably overfunded and constrained by investor demand. Clients can expect development of additional medical applications from the company, but be aware it competes with other noninvasive technologies on the market.

For the original news article, click here .


Further Reading

Qidni Labs

Company Snapshot | September 10, 2021

The company was started by Morteza Ahmadi in 2014. So far, the company has raised about $1.5 million over three rounds of funding, the latest being a nonequity assistance round in December 2020. Among its investors, we highlight L‑SPARK, 43North, and SOSV. The company makes a mobile kidney ... To read more, click here.

Prognoix

Company Profile | April 29, 2022

Prognoix is developing a wearable device, called the Tumeter, which monitors and provides differential analysis for ED Tumeter's core technology is its novel sensing technology that passively measures three clinically established data points of an erection — the engorgement, change of ... Not part of subscription

PKparis

Company Profile | May 19, 2022

Develops a smartwatch and app that monitor blood glucose levels to help support diabetics through its subsidiary PKvitality Claims differentiation in the ability to detect glucose in the body, while also monitoring calories, steps, and distance, but faces competition from other smartwatches and... Not part of subscription